Bebo HealthXPAR:MLBBO 47 Gross Margin % is 40.27% as of Dec. 2025, which is at its 10-year median of 40.27. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,113 Retail - Cyclical companies, Bebo Health ranks better than 58.4% on this metric.
Bebo Health SA gross margin has been in long-term decline. The average rate of decline per year is -2.9%.
The historical rank and industry rank for Bebo Health's Gross Margin % or its related term are showing as below:
XPAR:MLBBO'
s Gross Margin % Range Over the Past 10 Years
Min: 18.91 Med: 40.27 Max: 57.9
Current: 40.27
During the past 7 years, the highestGross Margin % of Bebo Health was 57.90%. The lowest was 18.91%. And the median was 40.27%.
XPAR:MLBBO's Gross Margin % is ranked better than 58.4% of 1113
companies
in the Retail - Cyclical industry
Industry Median: 36.37
vs XPAR:MLBBO: 40.27
Bebo Health had a gross margin of 40.27% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bebo Health was -2.90% per year.
Bebo Health (XPAR:MLBBO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bebo Health had a gross margin of 40.27% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bebo Health Gross Margin % Related Terms
Bebo Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bebo Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: Gross Margin % Comparison
For the Specialty Retail subindustry, Bebo Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health Gross Margin % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bebo Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bebo Health (XPAR:MLBBO) has a Gross Margin % of 40.27% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Bebo Health and its competitors. This is near median its historical median of 40.27. Over the past decade, Bebo Health's Gross Margin % has ranged from 18.91 to 57.90. According to the industry distribution chart, Bebo Health ranks #463 out of 1113 companies in the Retail - Cyclical industry, placing it in the top 41.6%.
Is Bebo Health's Gross Margin % too high?
Bebo Health's current Gross Margin % of 40.27% is near median its 10-year median of 40.27. Over the past 10 years, this metric has ranged from a low of 18.91 to a high of 57.90. The Retail - Cyclical industry median Gross Margin % is 36.37. Bebo Health's value of 40.27% is 10.7% above this industry median. Based on the distribution chart, Bebo Health ranks #463 out of 1113 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Gross Margin % compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #463 out of 1113 companies for Gross Margin %. This puts Bebo Health in the upper half of its industry. The industry median Gross Margin % is 36.37. Bebo Health's value of 40.27% is 10.7% above this benchmark. Historically, Bebo Health's own Gross Margin % has ranged from 18.91 to 57.90 over the past decade. While the company's 10-year median is 40.27 vs. the industry median of 36.37, Bebo Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Retail - Cyclical company?
The median Gross Margin % among Retail - Cyclical companies is 36.37, based on 1,113 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current Gross Margin % of 40.27% is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median Gross Margin % is 36.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current Gross Margin % is 40.27%, which is near median its own 10-year median of 40.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current Gross Margin % is 40.27%, which is near median its 10-year median of 40.27 and 10.7% above the Retail - Cyclical industry median of 36.37. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Gross Margin % is 40.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
Gross Margin %: 40.27% (near median its 10-year median of 40.27)
GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
Industry Position: 10.7% above the Retail - Cyclical median (#463 of 1113)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 